Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Depreciation and Depletion (2016 - 2022)

Nutex Health's Depreciation and Depletion history spans 13 years, with the latest figure at $1564.0 for Q1 2022.

  • For Q1 2022, Depreciation and Depletion rose 48.39% year-over-year to $1564.0; the TTM value through Mar 2022 reached $5158.0, down 50.72%, while the annual FY2021 figure was $4648.0, 67.98% down from the prior year.
  • Depreciation and Depletion for Q1 2022 was $1564.0 at Nutex Health, down from $1656.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $16264.0 in Q1 2019 and bottomed at -$10908.0 in Q2 2019.
  • The 5-year median for Depreciation and Depletion is $1054.0 (2021), against an average of $2174.8.
  • The largest YoY upside for Depreciation and Depletion was 3664.81% in 2019 against a maximum downside of 2630.86% in 2019.
  • A 5-year view of Depreciation and Depletion shows it stood at -$773.0 in 2018, then skyrocketed by 1321.86% to $9445.0 in 2019, then plummeted by 87.95% to $1138.0 in 2020, then surged by 45.52% to $1656.0 in 2021, then fell by 5.56% to $1564.0 in 2022.
  • Per Business Quant, the three most recent readings for NUTX's Depreciation and Depletion are $1564.0 (Q1 2022), $1656.0 (Q4 2021), and $968.0 (Q3 2021).